Clinical Trial Update: Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pembrolizumab plus standard chemotherapy as neoadjuvant therapy for locally advanced head and neck squamous cell carcinoma; currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Beijing Tongren Hospital | Conditions: Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy | Phase 3 | Status: RECRUITING